We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+9.43%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$230B
AUM Growth
+$18.4B
Cap. Flow
-$8.18B
Cap. Flow %
-3.55%
Top 10 Hldgs %
23.04%
Holding
10,299
New
1,220
Increased
3,476
Reduced
4,117
Closed
1,266

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$615M
2
UBER icon
Uber
UBER
+$551M
3
EXPE icon
Expedia Group
EXPE
+$523M
4
PYPL icon
PayPal
PYPL
+$452M
5
ETN icon
Eaton
ETN
+$408M

Sector Composition

Rank Sector Weight
1 Technology 5.14%
2 Financials 4.52%
3 Industrials 4.17%
4 Healthcare 3.91%
5 Consumer Discretionary 3.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATOS icon
8776
CALL
Atossa Therapeutics
ATOS
$24.1M
$17K ﹤0.01%
733
-87
-11% -$2.04K
CARM
8777
PUT
DELISTED
Carisma Therapeutics
CARM
$17K ﹤0.01%
825
-565
-41% -$13K
FRSX
8778
Foresight Autonomous Holdings
FRSX
$3.7M
$17K ﹤0.01%
+138
New +$21.6K
GPUS
8779
Hyperscale Data Inc
GPUS
$54.1M
0
GGE
8780
DELISTED
Green Giant Inc. Common Stock
GGE
$17K ﹤0.01%
+12,359
New +$18.6K
MLNT
8781
CALL
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$17K ﹤0.01%
31,300
-11,400
-27% -$27.6K
HDSN
8782
Hudson Technologies
HDSN
$238M
$16K ﹤0.01%
+15,947
New +$10.7K
LVO icon
8783
LiveOne
LVO
$56.9M
$16K ﹤0.01%
+1,015
New +$17.5K
TWAV
8784
TaoWeave Inc
TWAV
$4.84M
$16K ﹤0.01%
+20
New +$13.4K
TGB
8785
Trekor Metals
TGB
$3.01B
$16K ﹤0.01%
32,059
-12,549
-28% -$5.3K
ZVRA icon
8786
Zevra Therapeutics
ZVRA
$702M
$16K ﹤0.01%
+2,606
New +$20.7K
IDEX
8787
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$16K ﹤0.01%
152
+32
+27% +$4.27K
ASAP
8788
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
$16K ﹤0.01%
2,510
-7,080
-74% -$78.4K
MOSC.WS
8789
DELISTED
Mosaic Acquisition Corp. Warrants, each exercisable for one Class A Common Stock at an exercise pric
MOSC.WS
$16K ﹤0.01%
+16,397
New +$14K
EVOL
8790
DELISTED
Evolving Systems, Inc.
EVOL
$16K ﹤0.01%
+17,445
New +$17.8K
CAPR icon
8791
Capricor Therapeutics
CAPR
$242M
$15K ﹤0.01%
+11,400
New +$23.5K
CHRN
8792
ChronoScale Holdings
CHRN
$2.94B
$15K ﹤0.01%
166
+67
+68% +$8.3K
GSAT icon
8793
CALL
Globalstar
GSAT
$10.7B
$15K ﹤0.01%
1,940
+193
+11% +$1.17K
MVIS icon
8794
Microvision
MVIS
$76.1M
$15K ﹤0.01%
1,397
-670
-32% -$7.36K
VTAK icon
8795
Catheter Precision
VTAK
$977K
0
TTOO
8796
PUT
DELISTED
T2 Biosystems, Inc
TTOO
$15K ﹤0.01%
+3
New +$28.4K
IDEX
8797
PUT
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$15K ﹤0.01%
142
+6
+4% +$800
BLCM
8798
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$15K ﹤0.01%
+1,162
New +$10.7K
AQMS icon
8799
Aqua Metals
AQMS
$9.53M
$14K ﹤0.01%
93
-132
-59% -$34.4K
CLIR icon
8800
CALL
ClearSign Technologies
CLIR
$26.1M
$14K ﹤0.01%
+1,900
New +$18.5K

Similar funds

Citadel Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, Citadel Advisors held 10,299 positions worth $230B, up 8.7% from $212B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Citadel Advisors withdrew a net $8.18B in Q4 2019, closing 1,266 positions and reducing 4,117 holdings. Its most notable exit was Celgene Corp, an estimated $681M position sold in full.

By sector, the portfolio is most concentrated in Technology at 5.1% of assets, down from 5.3% a quarter earlier, followed by Financials and Industrials.

Against the trend, Citadel Advisors opened a new position in Interxion Holding N.V. worth $83.9M.

  • Citadel Advisors's largest Q4 2019 buy was Interxion Holding N.V.: 1,000,931 shares worth $83.9M.
  • Citadel Advisors added most to Amazon in Q4 2019, an estimated $615M increase.
  • Citadel Advisors's biggest Q4 2019 reduction was Raytheon Company, cutting an estimated $543M.
  • Citadel Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $681M.
  • Citadel Advisors's ten largest holdings make up 23% of its $230B portfolio in Q4 2019.
  • Citadel Advisors opened 1,220 new positions and closed 1,266 in Q4 2019.
  • Citadel Advisors's portfolio value rose 8.7% quarter-over-quarter to $230B.

Based on Citadel Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.